Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 24,000 shares at $40.00 ($890K) on 2020-12-16, disclosed to the SEC on 2020-12-16.
Open-market sale of $890k FREQ by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 8,000 | $280K | 31.5% |
| 2 | $37.28 | 8,000 | $298K | 33.5% |
| 3 | $37.87 | 4,000 | $151K | 17.0% |
| 4 | $40.00 | 4,000 | $160K | 18.0% |
| Total | $37.07 avg | 24,000 | $890K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |